ARTICLE | Company News
Alfama, hemoCORM Ltd. deal
September 15, 2008 7:00 AM UTC
The two developers of carbon monoxide (CO)-releasing therapeutics will merge. The combined company, which will retain Alfama's name, has preclinical CO programs to treat acute liver failure and multip...